Image from Google Jackets

Genentech : the beginnings of biotech Sally Smith Hughes.

By: Series: Synthesis (University of Chicago. Press)Publication details: London : University of Chicago Press, 2011.Description: xv, 213 pages : illustrations ; 24 cmISBN:
  • 9780226045511 (Pbk)
Subject(s): DDC classification:
  • 338.7 H874G 23
LOC classification:
  • HD9999.B444 H85 2011
Contents:
1. Inventing recombinant DNA technology ; Scientists on converging paths ;The collaboration ; Patenting and politics ; Steps toward commercialization -- 2. Creating Genentech ; Bob Swanson ; Founding Genentech ; Legal and political obstacles ; A full business plan -- 3. Proving the technology ; A portentous experiment ; Switching targets ; Negotiating research agreements -- Making somatostatin ; Wider issues -- 4. Human insulin: Genentech makes its mark ; Seeking corporate contracts; Procuring a facility and staff ; Genentech's human insulin project ; The Eli Lilly contract ; Publicity and expansion -- 5. Human growth hormone: shaping a commercial future ; Competing for human growth hormone ; Moving toward corporate integration ; Scaling up insulin and growth hormone ; Corporate expansion ; An emerging culture -- 6. Wall Street debut ; Biomania ; Exit strategies ; Interferon: the new wonder drug? ; Run-up to an initial public offering ; Legal impediments ; The IPO.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Notes Date due Barcode
Books Books Central Library, IISER Bhopal Reference Section Reference 338.7 H874G (Browse shelf(Opens below)) Not For Loan Reserve 10153

Includes bibliographical references and index.

1. Inventing recombinant DNA technology ; Scientists on converging paths ;The collaboration ; Patenting and politics ; Steps toward commercialization -- 2. Creating Genentech ; Bob Swanson ; Founding Genentech ; Legal and political obstacles ; A full business plan -- 3. Proving the technology ; A portentous experiment ; Switching targets ; Negotiating research agreements -- Making somatostatin ; Wider issues -- 4. Human insulin: Genentech makes its mark ; Seeking corporate contracts; Procuring a facility and staff ; Genentech's human insulin project ; The Eli Lilly contract ; Publicity and expansion -- 5. Human growth hormone: shaping a commercial future ; Competing for human growth hormone ; Moving toward corporate integration ; Scaling up insulin and growth hormone ; Corporate expansion ; An emerging culture -- 6. Wall Street debut ; Biomania ; Exit strategies ; Interferon: the new wonder drug? ; Run-up to an initial public offering ; Legal impediments ; The IPO.

There are no comments on this title.

to post a comment.


Contact for Queries: skpathak@iiserb.ac.in